Evaluation of efficiency of screening extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in hospitals where the bacteria are increasingly prevalent

Journal of Clinical Microbiology

Volumn 39, Issue 10, 2001, Pages 3696-3699

  Lee, K ^a   Lim, J K ^a   Yong, D ^a   Yum, J ^a   Chong, Y ^a   Okamoto, R ^a   Inoue, M ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CLAVULANIC ACID;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFOTAXIME; CEFTAZIDIME; CLAVULANIC ACID; DRUG STABILITY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HOSPITALS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PREVALENCE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA;

EID: 0034787683     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.10.3696-3699.2001     Document Type: Article

References (15)

1. Plasmid-encoded AmpC β-lactamases: How far have we gone 10 years after the discovery?
2. Incompatibility
3. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein
4. A functional classification scheme for β-lactamases and its correlation with molecular structure
5. Characteristics of extended-spectrum β-lactam hydrolyzing activity of Klebsiella pneumoniae and Escherichia coli strains isolated from clinical specimens
6. Survey of Klebsiella pneumoniae strains producing extended-spectrum β-lactamases: Prevalence of SHV-12 and SHV-2a in Korea
7. Korean nationwide surveillance of antimicrobial resistance of bacteria in 1998
8. β-Lactamases in laboratory and clinical resistance
9. The use of analytical isoelectric focusing for detection and identification of β-lactamases
10. Survey of extended-spectrum β-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: Prevalence of TEM-52 in Korea
11. Use of microdilution panels with and without β-lactamase inhibitors as a phenotypic test for β-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens
12. Evaluation of stability of cefotaxime (30-μg) and ceftazidime (30-μg) disks impregnated with clavulanic acid (10 μg/ml) for detection of extended-spectrum β-lactamases